Fig. 2From: Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinomaFrequency of non-synonymous mutations in the top 10 frequently mutated genes in pre- and post- treatment with carboplatin/paclitaxel and radiation in patients with EACBack to article page